Ahmad Tajudin Liza-Sharmini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmad Tajudin Liza-Sharmini has a total of 531 co-authors. Here are the top co-authors by number of shared publications:
- Azhany Yaakub
Department of Ophthalmology and Visual Sciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
17 shared publications - Chiea Chuen Khor
Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore
5 shared publications - Paul J. Foster
Institute of Ophthalmology, UCL, London, UK
5 shared publications Y Azhany
1,2,4Department of Ophthalmology & Visual Science, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia
5 shared publicationsYaakub Azhany
Department of Ophthalmology and Visual Science, School of Medical Sciences, Health campus, Universiti Sains Malaysia and Hospital Pakar Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
5 shared publications- Bin Alwi Zilfalil
Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
4 shared publications
Latest Publications
- 25 June 2026
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (6) , 1661-1669
Predictive factors and development of traumatic angle recession glaucoma following blunt ocular trauma
Purpose: To predict the development of traumatic angle recession glaucoma (TARG) and identify associated risk factors using Kaplan–Meier survival analysis. Materials and Methods: This retrospective cohort study was conducted across three tertiary hospitals in Malaysia, involving patients treated for blunt ocular trauma and traumatic hyphaema between 1 January 2010 and 31 December 2020. Eligible patients had a minimum of one year of follow-up between 1 January and 31 December 2021. Data collected included demographics, medical and ocular history, injury mechanism, and initial ophthalmic assessment. Kaplan–Meier survival analysis and Cox proportional hazards regression were employed to evaluate glaucoma onset and prognostic indicators. Results: Of 114 patients with angle recession, 30 (26.3%) developed TARG over a mean follow-up of 66.8 ± 52.1 months. Kaplan–Meier analysis estimated a mean survival time of 8.8 years, with most cases detected within nine months post-trauma. Age was a significant predictor, with a 1% increased risk per year (HR 1.02; 95% CI: 1.00–1.04; p = 0.022). Presence of peripheral anterior synechiae (PAS) conferred a 4.3-fold higher risk of developing TARG (HR 4.29; 95% CI: 2.02–9.13; p < 0.001). Conclusion: Older patients with PAS following blunt ocular trauma are at significantly increased risk for TARG and warrant close surveillance. Further research is needed to establish optimal follow-up duration and develop predictive tools for early identification of high-risk individuals.
- 25 June 2026
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (6) , 1661-1669
Predictive factors and development of traumatic angle recession glaucoma following blunt ocular trauma
Purpose: To predict the development of traumatic angle recession glaucoma (TARG) and identify associated risk factors using Kaplan–Meier survival analysis. Materials and Methods: This retrospective cohort study was conducted across three tertiary hospitals in Malaysia, involving patients treated for blunt ocular trauma and traumatic hyphaema between 1 January 2010 and 31 December 2020. Eligible patients had a minimum of one year of follow-up between 1 January and 31 December 2021. Data collected included demographics, medical and ocular history, injury mechanism, and initial ophthalmic assessment. Kaplan–Meier survival analysis and Cox proportional hazards regression were employed to evaluate glaucoma onset and prognostic indicators. Results: Of 114 patients with angle recession, 30 (26.3%) developed TARG over a mean follow-up of 66.8 ± 52.1 months. Kaplan–Meier analysis estimated a mean survival time of 8.8 years, with most cases detected within nine months post-trauma. Age was a significant predictor, with a 1% increased risk per year (HR 1.02; 95% CI: 1.00–1.04; p = 0.022). Presence of peripheral anterior synechiae (PAS) conferred a 4.3-fold higher risk of developing TARG (HR 4.29; 95% CI: 2.02–9.13; p < 0.001). Conclusion: Older patients with PAS following blunt ocular trauma are at significantly increased risk for TARG and warrant close surveillance. Further research is needed to establish optimal follow-up duration and develop predictive tools for early identification of high-risk individuals.
- Open Access
- 20 February 2026
- Published by Kugler Publications in Malaysian Journal of Ophthalmology
- Vol. 8 (1) , 8-11
Joint position statement: Strengthening eye screening for newborns and pre-schoolers in Malaysia
The Malaysian Society of Ophthalmology, the College of Ophthalmologists, the Malaysia Advocacy for Myopia Prevention, the Association of Malaysian Optometrists, the Malaysian Association of Practising Opticians, and the Malaysian Paediatric Association present this joint position statement firmly recommending an all-of-Malaysia effort to strengthen eye screening for all children nationwide in Malaysia, especially for newborns aged 0–30 days and for preschoolers aged 5–6. This joint position statement is supported by colleagues from the Asia-Pacific Paediatric Retina Association (APPREA).
- 20 February 2026
- Published by Kugler Publications in Malaysian Journal of Ophthalmology
- Vol. 8 (1) , 8-11
Open AccessJoint position statement: Strengthening eye screening for newborns and pre-schoolers in Malaysia
The Malaysian Society of Ophthalmology, the College of Ophthalmologists, the Malaysia Advocacy for Myopia Prevention, the Association of Malaysian Optometrists, the Malaysian Association of Practising Opticians, and the Malaysian Paediatric Association present this joint position statement firmly recommending an all-of-Malaysia effort to strengthen eye screening for all children nationwide in Malaysia, especially for newborns aged 0–30 days and for preschoolers aged 5–6. This joint position statement is supported by colleagues from the Asia-Pacific Paediatric Retina Association (APPREA).
- Open Access
- 14 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10003
GWAS for primary angle-closure glaucoma identifies loci related to ocular biometry and morphology
GWAS of primary angle-closure glaucoma have identified eight loci conferring risk in Asian populations. However, it remains unclear whether the genetic risk factors for the disease are consistent across different populations. Here, we present a discovery GWAS for primary angle-closure glaucoma in Europeans using the UK Biobank. We replicate our findings in six independent European populations and compare these results with results from 14 Asian cohorts. Five genomic regions in the discovery cohort are associated at genome-wide significance, including two loci previously identified in Asian cohorts. We next meta-analyse the discovery and replication cohorts to identify six additional novel loci, all previously associated with refractive error. Mendelian randomisation provides evidence for a causal role of shorter axial length and hypermetropic refractive error on primary angle-closure glaucoma. A polygenic risk score derived from the European ancestry meta-analysis demonstrates significant associations with quantitative ocular traits – including a shallower anterior chamber and higher intraocular pressure – in the independent EPIC-Norfolk cohort. Finally, a multi-ancestry meta-analysis of all 21 European and Asian cohorts identifies 12 further novel loci. This work shows that genetic factors associated with a darker iris and hypermetropia confer risk for primary angle-closure glaucoma.
- 14 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10003
Open AccessGWAS for primary angle-closure glaucoma identifies loci related to ocular biometry and morphology
GWAS of primary angle-closure glaucoma have identified eight loci conferring risk in Asian populations. However, it remains unclear whether the genetic risk factors for the disease are consistent across different populations. Here, we present a discovery GWAS for primary angle-closure glaucoma in Europeans using the UK Biobank. We replicate our findings in six independent European populations and compare these results with results from 14 Asian cohorts. Five genomic regions in the discovery cohort are associated at genome-wide significance, including two loci previously identified in Asian cohorts. We next meta-analyse the discovery and replication cohorts to identify six additional novel loci, all previously associated with refractive error. Mendelian randomisation provides evidence for a causal role of shorter axial length and hypermetropic refractive error on primary angle-closure glaucoma. A polygenic risk score derived from the European ancestry meta-analysis demonstrates significant associations with quantitative ocular traits – including a shallower anterior chamber and higher intraocular pressure – in the independent EPIC-Norfolk cohort. Finally, a multi-ancestry meta-analysis of all 21 European and Asian cohorts identifies 12 further novel loci. This work shows that genetic factors associated with a darker iris and hypermetropia confer risk for primary angle-closure glaucoma.
- Open Access
- 15 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7620
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Primary angle-closure glaucoma is a major cause of irreversible blindness worldwide afflicting >20 million people. Through whole exome sequencing, we analysed the association between gene-based burden of rare, protein-altering genetic variants and disease risk in 4,667 affected individuals and 5,473 unaffected controls. We tested genes surpassing exome-wide significance (P < 2.5 × 10-6) for replication in a further 2,519 cases and 472,189 controls. We observed carriers of rare, protein-altering variants at UBOX5 (observed in 154 out of 7,186 affected individuals [2.1%] and in 3,975 out of 477,197 unaffected controls [0.83%]) to be associated with 2.13-fold increased risk of PACG (95%ci, 1.69 – 2.69; P = 1.25 × 10-10). We performed substrate trapping assays coupled with mass spectrometry and observed Binding Immunoglobulin Protein (BIP) as a key substrate for UBOX5. Biological assays showed UBOX5 acts by ubiquitinating BIP. We evaluated the functional status of 35 UBOX5 variants and observed that functionally deficient variants were enriched in affected individuals compared to controls. We validated this finding in an independent collection where 3 persons carrying functionally deficient variants were observed out of 208 cases (1.4%), whereas none were observed in 600 controls. Our findings suggest the UBOX5—BIP signalling pathway might be involved in biology of primary angle-closure glaucoma.
- 15 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 7620
Open AccessFunctionally deficient UBOX5 variants and primary angle-closure glaucoma
Primary angle-closure glaucoma is a major cause of irreversible blindness worldwide afflicting >20 million people. Through whole exome sequencing, we analysed the association between gene-based burden of rare, protein-altering genetic variants and disease risk in 4,667 affected individuals and 5,473 unaffected controls. We tested genes surpassing exome-wide significance (P < 2.5 × 10-6) for replication in a further 2,519 cases and 472,189 controls. We observed carriers of rare, protein-altering variants at UBOX5 (observed in 154 out of 7,186 affected individuals [2.1%] and in 3,975 out of 477,197 unaffected controls [0.83%]) to be associated with 2.13-fold increased risk of PACG (95%ci, 1.69 – 2.69; P = 1.25 × 10-10). We performed substrate trapping assays coupled with mass spectrometry and observed Binding Immunoglobulin Protein (BIP) as a key substrate for UBOX5. Biological assays showed UBOX5 acts by ubiquitinating BIP. We evaluated the functional status of 35 UBOX5 variants and observed that functionally deficient variants were enriched in affected individuals compared to controls. We validated this finding in an independent collection where 3 persons carrying functionally deficient variants were observed out of 208 cases (1.4%), whereas none were observed in 600 controls. Our findings suggest the UBOX5—BIP signalling pathway might be involved in biology of primary angle-closure glaucoma.
- Open Access
- 31 July 2025
- Published by Jaypee Brothers Medical Publishing in Journal of Current Glaucoma Practice
- Vol. 19 (2) , 79-84
Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia
Erectile dysfunction (ED) and primary open-angle glaucoma (POAG) are common in the elderly population. The current study aimed at assessing the incidence of ED and its correlation with POAG severity in Malaysia. A cross-sectional study at three Malaysian suburban ophthalmology clinics was conducted from September 2019 to 2020. A total of 220 participants aged 40-80 years completed a validated Malay version of the International Index of Erectile Function-5 (IIEF-5). Glaucoma severity was classified using a revised Advanced Glaucoma Intervention Study (AGIS) score. Medical history, ocular parameters, and treatments were reviewed. The participants' mean age was found to be 69.3 (±7.5) years, with prevalence of ED being 91%. IIEF-5 scores significantly declined with increasing glaucoma severity (p < 0.001), even after adjusting for comorbidities and topical beta-blockers. AGIS and IIEF-5 scores were significantly correlated (r = -0.262, p = 0.010). The incidence of ED increased by 1.23 times (OR = 1.23, 95% CI: 1.10-1.38) with the increase of every year in age. ED was not influenced by diabetes, hypertension, hyperlipidemia, or topical beta-blockers. ED is common among POAG patients and increases with glaucoma severity. The association between ED and POAG is influenced by aging, complicating the determination of a direct relationship. This study highlights the potential association between vision impairment, specifically glaucoma, and sexual health in men. Focusing on sexual health in glaucoma patients is vital in order to improve overall quality of life (QoL) as well as ensure a holistic approach to patient care. Given the commonness of both conditions in older adults, this research provides insights into the significance of taking sexual health into consideration in the comprehensive treatment of glaucoma. Chee CC, Sabah H, Yaakub A, et al. Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia. J Curr Glaucoma Pract 2025;19(2):79-84.
- 31 July 2025
- Published by Jaypee Brothers Medical Publishing in Journal of Current Glaucoma Practice
- Vol. 19 (2) , 79-84
Open AccessErectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia
Erectile dysfunction (ED) and primary open-angle glaucoma (POAG) are common in the elderly population. The current study aimed at assessing the incidence of ED and its correlation with POAG severity in Malaysia. A cross-sectional study at three Malaysian suburban ophthalmology clinics was conducted from September 2019 to 2020. A total of 220 participants aged 40-80 years completed a validated Malay version of the International Index of Erectile Function-5 (IIEF-5). Glaucoma severity was classified using a revised Advanced Glaucoma Intervention Study (AGIS) score. Medical history, ocular parameters, and treatments were reviewed. The participants' mean age was found to be 69.3 (±7.5) years, with prevalence of ED being 91%. IIEF-5 scores significantly declined with increasing glaucoma severity (p < 0.001), even after adjusting for comorbidities and topical beta-blockers. AGIS and IIEF-5 scores were significantly correlated (r = -0.262, p = 0.010). The incidence of ED increased by 1.23 times (OR = 1.23, 95% CI: 1.10-1.38) with the increase of every year in age. ED was not influenced by diabetes, hypertension, hyperlipidemia, or topical beta-blockers. ED is common among POAG patients and increases with glaucoma severity. The association between ED and POAG is influenced by aging, complicating the determination of a direct relationship. This study highlights the potential association between vision impairment, specifically glaucoma, and sexual health in men. Focusing on sexual health in glaucoma patients is vital in order to improve overall quality of life (QoL) as well as ensure a holistic approach to patient care. Given the commonness of both conditions in older adults, this research provides insights into the significance of taking sexual health into consideration in the comprehensive treatment of glaucoma. Chee CC, Sabah H, Yaakub A, et al. Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia. J Curr Glaucoma Pract 2025;19(2):79-84.
- Open Access
- 22 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77835
From Blurred Vision to Stage IV Lung Cancer: Choroidal Metastases
Metastatic choroidal tumors are the most common type of intraocular malignancy and are often linked to advanced-stage systemic cancers. Lung cancer, a leading cause of cancer-related mortality worldwide, occasionally presents with choroidal metastasis as the initial sign of systemic disease. This case series, which presents two distinct presentations of choroidal metastases as the first clinical manifestation of advanced lung adenocarcinoma, contributes to the understanding of the atypical presentations of lung cancer and the importance of considering ocular symptoms in the diagnosis of systemic diseases.
- 22 January 2025
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e77835
Open AccessFrom Blurred Vision to Stage IV Lung Cancer: Choroidal Metastases
Metastatic choroidal tumors are the most common type of intraocular malignancy and are often linked to advanced-stage systemic cancers. Lung cancer, a leading cause of cancer-related mortality worldwide, occasionally presents with choroidal metastasis as the initial sign of systemic disease. This case series, which presents two distinct presentations of choroidal metastases as the first clinical manifestation of advanced lung adenocarcinoma, contributes to the understanding of the atypical presentations of lung cancer and the importance of considering ocular symptoms in the diagnosis of systemic diseases.
- Open Access
- 29 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e76598
Therapeutic Dilemma of a Juxtapapillary Retinal Capillary Hemangioma
A juxtapapillary retinal capillary hemangioma (JRCH) is a rare vascular hamartoma located on the optic nerve head or adjacent region. While often associated with von Hippel-Lindau (VHL) disease, JRCHs can also occur as an isolated condition, presenting unique therapeutic challenges and risks of visual impairment. We report a case of a 50-year-old Malay gentleman with diabetes mellitus who presented with a non-progressive superior visual field defect in his left eye for three months. Fundus examination revealed a raised reddish mass adjacent to the nasal optic disc, accompanied by macular exudates. Optical coherence tomography confirmed cystoid macular oedema, while fundus fluorescence angiography revealed feeder and draining vessels with late leakage and adjacent small vessel vasculitis. Systemic evaluation found no evidence of VHL or other abnormalities. Despite treatment with photodynamic therapy and intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, the patient’s vision progressively deteriorated. This case highlights the diagnostic and therapeutic challenges associated with JRCH and emphasizes the need for early recognition and tailored interventions to mitigate significant visual impairment.
- 29 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e76598
Open AccessTherapeutic Dilemma of a Juxtapapillary Retinal Capillary Hemangioma
A juxtapapillary retinal capillary hemangioma (JRCH) is a rare vascular hamartoma located on the optic nerve head or adjacent region. While often associated with von Hippel-Lindau (VHL) disease, JRCHs can also occur as an isolated condition, presenting unique therapeutic challenges and risks of visual impairment. We report a case of a 50-year-old Malay gentleman with diabetes mellitus who presented with a non-progressive superior visual field defect in his left eye for three months. Fundus examination revealed a raised reddish mass adjacent to the nasal optic disc, accompanied by macular exudates. Optical coherence tomography confirmed cystoid macular oedema, while fundus fluorescence angiography revealed feeder and draining vessels with late leakage and adjacent small vessel vasculitis. Systemic evaluation found no evidence of VHL or other abnormalities. Despite treatment with photodynamic therapy and intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, the patient’s vision progressively deteriorated. This case highlights the diagnostic and therapeutic challenges associated with JRCH and emphasizes the need for early recognition and tailored interventions to mitigate significant visual impairment.
- Open Access
- 13 May 2023
- Published by Jaypee Brothers Medical Publishing in Journal of Current Glaucoma Practice
- Vol. 17 (1) , 3-8
Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese
To compare anterior segment biometry parameters in progress and non-progress primary angle closure glaucoma (PACG) among Malay and Chinese patients. A cross-sectional study was conducted between November 2015 and December 2016 involving 75 patients with PACG (43 Malays and 32 Chinese) who were recruited from a single glaucoma center in Malaysia. Ocular examination included anterior segment biometry measurements on the selected eye. Axial length (AL) and anterior chamber depth (ACD) measurement was done using a noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior chamber angle (ACA) was measured by Anterior Segment-OCT (Spectralis Heidelberg, Germany). Humphrey visual field (HVF) 24-2 analysis of the same eye was conducted and compared with the HVF when diagnosis was made. Progression of PACG patients was assessed according to the Hodapp, Parrish and Anderson's (HPA) classification, they were then divided into progress and non-progress groups. Comparison of anterior segment biometry parameters between Malay and Chinese PACG patients with and without progression was analyzed using independent T test. Multivariate ANOVA analysis was used to compare the anterior segment parameters between progress and non-progress PACG patients, with adjustment for age, gender, lens status, family history and presence of diabetes mellitus. Chinese PACG patients have significant shorter AL (22.18 mm ± 0.76) and narrower ACA (11.96° ± 6.00) compared to Malay PACG patients. Among the progress group, Chinese PACG patients have significant shorter AL, shallower ACD and narrower ACA compared to Malays. However, after controlling for confounding factors, there was significant difference in ACA between Malay and Chinese PACG. There was also no significant difference of ocular biometry measurement between Chinese and Malay patients in progress and non-progress group. There was racial influence in ocular biometry measurement in PACG patients. Chinese have significant narrower ACA compared to Malays. Serial AS-OCT monitoring is important in management of PACG. Neoh FP, Azhany Y, Siti-Azrin AH, et al. Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese. J Curr Glaucoma Pract 2023;17(1):3-8.
- 13 May 2023
- Published by Jaypee Brothers Medical Publishing in Journal of Current Glaucoma Practice
- Vol. 17 (1) , 3-8
Open AccessAnterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese
To compare anterior segment biometry parameters in progress and non-progress primary angle closure glaucoma (PACG) among Malay and Chinese patients. A cross-sectional study was conducted between November 2015 and December 2016 involving 75 patients with PACG (43 Malays and 32 Chinese) who were recruited from a single glaucoma center in Malaysia. Ocular examination included anterior segment biometry measurements on the selected eye. Axial length (AL) and anterior chamber depth (ACD) measurement was done using a noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior chamber angle (ACA) was measured by Anterior Segment-OCT (Spectralis Heidelberg, Germany). Humphrey visual field (HVF) 24-2 analysis of the same eye was conducted and compared with the HVF when diagnosis was made. Progression of PACG patients was assessed according to the Hodapp, Parrish and Anderson's (HPA) classification, they were then divided into progress and non-progress groups. Comparison of anterior segment biometry parameters between Malay and Chinese PACG patients with and without progression was analyzed using independent T test. Multivariate ANOVA analysis was used to compare the anterior segment parameters between progress and non-progress PACG patients, with adjustment for age, gender, lens status, family history and presence of diabetes mellitus. Chinese PACG patients have significant shorter AL (22.18 mm ± 0.76) and narrower ACA (11.96° ± 6.00) compared to Malay PACG patients. Among the progress group, Chinese PACG patients have significant shorter AL, shallower ACD and narrower ACA compared to Malays. However, after controlling for confounding factors, there was significant difference in ACA between Malay and Chinese PACG. There was also no significant difference of ocular biometry measurement between Chinese and Malay patients in progress and non-progress group. There was racial influence in ocular biometry measurement in PACG patients. Chinese have significant narrower ACA compared to Malays. Serial AS-OCT monitoring is important in management of PACG. Neoh FP, Azhany Y, Siti-Azrin AH, et al. Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese. J Curr Glaucoma Pract 2023;17(1):3-8.
- Open Access
- 17 April 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (8) , 7372
Clinical and Histopathological Effects of Intracameral Ranibizumab in Experimental Trabeculectomy
Post-surgical scarring is a known cause of trabeculectomy failure. The aim of this study was to investigate the effectiveness of ranibizumab as an adjuvant anti-scarring agent in experimental trabeculectomy. Forty New Zealand white rabbits were randomised into four eye treatment groups: groups A (control), B (ranibizumab 0.5 mg/mL), C (mitomycin C [MMC] 0.4 mg/mL), and D (ranibizumab 0.5 mg/mL and MMC 0.4 mg/mL). Modified trabeculectomy was performed. Clinical parameters were assessed on post-operative days 1, 2, 3, 7, 14, and 21. Twenty rabbits were euthanised on day 7, and the other twenty were euthanised on day 21. Eye tissue samples were obtained from the rabbits and stained with haematoxylin and eosin (H&E). All treatment groups showed a significant difference in IOP reduction compared with group A (p < 0.05). Groups C and D showed a significant difference in bleb status on days 7 (p = 0.001) and 21 (p = 0.002) relative to group A. H&E staining showed significantly low fibrotic activity (p < 0.001) in group C on both days and inflammatory cell grade in group B on day 7 (p < 0.001). The grade for new vessel formation was significantly low in groups B and D on day 7 (p < 0.001) and in group D on day 21 (p = 0.007). Ranibizumab plays a role in reducing scarring, and a single application of the ranibizumab–MMC combination showed a moderate wound-modulating effect in the early post-operative phase.
- 17 April 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (8) , 7372
Open AccessClinical and Histopathological Effects of Intracameral Ranibizumab in Experimental Trabeculectomy
Post-surgical scarring is a known cause of trabeculectomy failure. The aim of this study was to investigate the effectiveness of ranibizumab as an adjuvant anti-scarring agent in experimental trabeculectomy. Forty New Zealand white rabbits were randomised into four eye treatment groups: groups A (control), B (ranibizumab 0.5 mg/mL), C (mitomycin C [MMC] 0.4 mg/mL), and D (ranibizumab 0.5 mg/mL and MMC 0.4 mg/mL). Modified trabeculectomy was performed. Clinical parameters were assessed on post-operative days 1, 2, 3, 7, 14, and 21. Twenty rabbits were euthanised on day 7, and the other twenty were euthanised on day 21. Eye tissue samples were obtained from the rabbits and stained with haematoxylin and eosin (H&E). All treatment groups showed a significant difference in IOP reduction compared with group A (p < 0.05). Groups C and D showed a significant difference in bleb status on days 7 (p = 0.001) and 21 (p = 0.002) relative to group A. H&E staining showed significantly low fibrotic activity (p < 0.001) in group C on both days and inflammatory cell grade in group B on day 7 (p < 0.001). The grade for new vessel formation was significantly low in groups B and D on day 7 (p < 0.001) and in group D on day 21 (p = 0.007). Ranibizumab plays a role in reducing scarring, and a single application of the ranibizumab–MMC combination showed a moderate wound-modulating effect in the early post-operative phase.
- Open Access
- 28 March 2023
- Published by Springer Nature in Cureus
- Vol. 15 (3)
Wall-Eyed Bilateral Internuclear Ophthalmoplegia as an Early Presentation of Multiple Sclerosis
Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) is a rare neuro-ophthalmological condition in which there is ocular motility impairment characterized by bilateral adduction deficiencies, bilateral abducting nystagmus, and exotropia in primary gaze, and is often associated with multiple sclerosis (MS). This report describes a young female who presented with sudden onset of binocular diplopia and alternating exotropia for two days duration, which was associated with a history of intermittent headaches for one year before presenting complaints. Examination revealed alternating exotropia on the primary gaze with bilateral limitation of adduction and bilateral nystagmus on abduction. Other ocular and neurological examinations were unremarkable. Neuroimaging showed multiple white matter lesions that were consistent with demyelinating disease. Her symptoms completely resolved after the initiation of intravenous corticosteroid therapy. However, she developed left upper limb numbness four months later, and a repeat magnetic resonance imaging (MRI) of the brain showed the presence of multiple new brain lesions. Subsequently, she was diagnosed with MS and started on immunotherapy. Her symptoms resolved, with no residual ophthalmoplegia or any neurological symptoms.
- 28 March 2023
- Published by Springer Nature in Cureus
- Vol. 15 (3)
Open AccessWall-Eyed Bilateral Internuclear Ophthalmoplegia as an Early Presentation of Multiple Sclerosis
Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) is a rare neuro-ophthalmological condition in which there is ocular motility impairment characterized by bilateral adduction deficiencies, bilateral abducting nystagmus, and exotropia in primary gaze, and is often associated with multiple sclerosis (MS). This report describes a young female who presented with sudden onset of binocular diplopia and alternating exotropia for two days duration, which was associated with a history of intermittent headaches for one year before presenting complaints. Examination revealed alternating exotropia on the primary gaze with bilateral limitation of adduction and bilateral nystagmus on abduction. Other ocular and neurological examinations were unremarkable. Neuroimaging showed multiple white matter lesions that were consistent with demyelinating disease. Her symptoms completely resolved after the initiation of intravenous corticosteroid therapy. However, she developed left upper limb numbness four months later, and a repeat magnetic resonance imaging (MRI) of the brain showed the presence of multiple new brain lesions. Subsequently, she was diagnosed with MS and started on immunotherapy. Her symptoms resolved, with no residual ophthalmoplegia or any neurological symptoms.